Association Between Interleukin 6 and C-Reactive Protein Serum Levels and Body Composition Compartments and Components in Breast Cancer Survivors

Abstract

Obesity is highly prevalent in breast cancer (BC) survivors. Adipose tissue promotes inflammation, affecting recurrence, morbidity, and quality of life. This study aimed to determine the relationship of body composition parameters with the levels of C-reactive protein (CRP) and interleukin 6 (IL-6) in female BC survivors. Additionally, we evaluated the association of log-transformed serum concentrations of CRP and IL-6 with the appendicular skeletal lean mass index (ASMI). The results showed that CRP was positively associated with body fat percentage (BFP; β adjusted = .08, 95% CI: .02–.14) in all participants, and with fat mass index (FMI; β = .24, 95% CI: .08–.40) only in premenopausal women. IL-6 was positively associated with FMI (β adjusted = .16, 95% CI: .03–.29), while ASMI decreased as CRP levels increased (β adjusted = −.30, 95% CI: −.53 to −.06). Interventions to improve body composition in BC survivors should also consider the role of inflammatory markers in changes in body composition to avoid sarcopenic obesity (SO) and the risk of BC recurrence.

Keywords

breast cancer obesity interleukin 6 C-reactive protein fat mass index appendicular skeletal lean mass index

Get full access to this article

View all access options for this article.

References

Ahmed

S. A.

Hamed

M. A.

Omar

O. S.

(2015). Clinical utility of certain biomarkers as predictors of breast cancer with or without metastasis among Egyptian females. Tumour biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, 36(2), 815–822. Article 2. https://doi.org/10.1007/s13277-014-2689-z

Alemán

Esparza

Ramirez

F. A.

Astiazaran

Payette

(2011). Longitudinal evidence on the association between interleukin-6 and C-reactive protein with the loss of total appendicular skeletal muscle in free-living older men and women. Age and Ageing, 40(4), 469–475. Article 4. https://doi.org/10.1093/ageing/afr040

Allin

K. H.

Bojesen

S. E.

Nordestgaard

B. G.

(2009). C-reactive protein, risk of and survival after cancer—secondary publication. Ugeskrift for Laeger, 171(48), 3510–3513. 19953727.

Baracos

V. E.

(2018). Cancer-associated malnutrition. European Journal of Clinical Nutrition, 72(9), 1255–1259. Article 9. https://doi.org/10.1038/s41430-018-0245-4

Batsis

J. A.

Mackenzie

T. A.

Jones

J. D.

Lopez-Jimenez

Bartels

S. J.

(2016). Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999–2004 national health and nutrition examination Survey. Clinical Nutrition, 35(6), 1472–1483. Article 6. https://doi.org/10.1016/j.clnu.2016.03.028

Brown

J. C.

Schmitz

K. H.

(2015). Weight lifting and appendicular skeletal muscle mass among breast cancer survivors: A randomized controlled trial. Breast Cancer Research and Treatment, 151(2), 385–392. https://doi.org/10.1007/s10549-015-3409-0

Cesari

Kritchevsky

S. B.

Baumgartner

R. N.

Atkinson

H. H.

Penninx

B. W.

Lenchik

Palla

S. L.

Ambrosius

W. T.

Tracy

R. P.

Pahor

(2005). Sarcopenia, obesity, and inflammation-results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. The American Journal of Clinical Nutrition, 82(2), 428–434. Article 2. https://doi.org/10.1093/ajcn.82.2.428

Cruz-Jentoft

A. J.

Sayer

A. A.

(2019). Sarcopenia. Lancet (London, England), 393(10191), 2636–2646. Article 10191. https://doi.org/10.1016/S0140-6736(19)31138-9

Deluche

Leobon

Desport

J. C.

Venat-Bouvet

Usseglio

Tubiana-Mathieu

(2018). Impact of body composition on outcome in patients with early breast cancer. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 26(3), 861–868. Article 3. https://doi.org/10.1007/s00520-017-3902-6

10.

Dieli-Conwright

C. M.

Courneya

K. S.

Demark-Wahnefried

Sami

Lee

Buchanan

T. A.

Spicer

D. V.

Tripathy

Bernstein

Mortimer

J. E.

(2018). Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast cancer: A randomized controlled trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 36(9), 875–883. Article 9. https://doi.org/10.1200/JCO.2017.75.7526

11.

Dutra

Avelar

Souza

V. C.

Bottaro

Oliveira

Nóbrega

Moreno Lima

(2017). Relationship between sarcopenic obesity-related phenotypes and inflammatory markers in postmenopausal women. Clinical Physiology and Functional Imaging, 37(2), 205–210. https://doi.org/10.1111/cpf.12287

12.

Ebong

I. A.

Schreiner

Lewis

C. E.

Appiah

Ghelani

Wellons

(2016). The association between high sensitivity C-reactive protein and hypertension in women of the CARDIA study. Menopause, 23(6), 662–668. Article 6. https://doi.org/10.1097/GME.0000000000000609

13.

Engin

(2017). Obesity-associated breast cancer: Analysis of risk factors. Advances in Experimental Medicine and Biology, 960, 571–606. https://doi.org/10.1007/978-3-319-48382-5_25

14.

Favaro

Amadori

Indraccolo

(2008). Cellular interactions in the vascular niche: Implications in the regulation of tumor dormancy. Acta Pathologica, Microbiologica et Immunologica Scandinavica: Acta Pathologica, Microbiologica et Immunologica Scandinavica, 116(7–8), 648–659. Article 7. https://doi.org/10.1111/j.1600-0463.2008.01025.x

15.

Ferlay

Ervik

Lam

Colombet

Mery

Piñeros

Znaor

Soerjomataram

Bray

(2020). Cancer today. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer. http://gco.iarc.fr/today/home

16.

Fuentes

Vilahur

Badimon

Palomo

(2013). Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators of Inflammation, 2013(2013), Article e136584. https://doi.org/10.1155/2013/136584

17.

Gnagnarella

Dragà

Baggi

Simoncini

M. C.

Sabbatini

Mazzocco

Bassi

F. D.

Pravettoni

Maisonneuve

(2016). Promoting weight loss through diet and exercise in overweight or obese breast cancer survivors (InForma): Study protocol for a randomized controlled trial. Trials, 17(1), 363. Article 1. https://doi.org/10.1186/s13063-016-1487-x

18.

Iwase

Sangai

Nagashima

Sakakibara

Hayama

Ishigami

Masuda

Miyazaki

(2016). Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients. Cancer Medicine, 5(1), 41–48. Article 1. https://doi.org/10.1002/cam4.571

19.

Izaola

de Luis

Sajoux

Domingo

J. C.

Vidal

(2015). Inflamación y obesidad (lipoinflamación). Nutricion Hospitalaria, 31(6), 2352–2358. Article 6. https://doi.org/10.3305/nh.2015.31.6.8829

20.

Jones

S. B.

Thomas

G. A.

Hesselsweet

S. D.

Alvarez-Reeves

Irwin

M. L.

(2013). Effect of exercise on markers of inflammation in breast cancer survivors: The Yale exercise and survivorship study. Cancer Prevention Research(6(2), 109–118. Article 2. https://doi.org/10.1158/1940-6207.CAPR-12-0278

21.

Kelly

T. L.

Wilson

K. E.

Heymsfield

S. B.

(2009). Dual energy X-ray absorptiometry body composition reference values from NHANES. PLoS One, 4(9), Article e7038. Article 9. https://doi.org/10.1371/journal.pone.0007038

22.

Khan

Shukla

Sinha

Meeran

S. M.

(2013). Role of adipokines and cytokines in obesity-associated breast cancer: Therapeutic targets. Cytokine and Growth Factor Reviews, 24(6), 503–513. Article 6. https://doi.org/10.1016/j.cytogfr.2013.10.001

23.

Kinoshita

Tajiri

(2013). Cancer and inflammation: Suppress inflammation, suppress cancer? Journal of Translational Medicine & Epidemiology, 1, 1004. https://www.jscimedcentral.com/public/assets/articles/translationalmedicine-1-1004.pdf.

24.

Kozakowski

Gietka-Czernel

Leszczyńska

Majos

(2017). Obesity in menopause–our negligence or an unfortunate inevitability? Przegla̜d Menopauzalny = Menopause Review, 16(2), 61–65. Article 2. https://doi.org/10.5114/pm.2017.68594

25.

Kozłowski

Zakrzewska

Tokajuk

Wojtukiewicz

M. Z.

(2003). Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Roczniki Akademii Medycznej w Bialymstoku, 48, 82–84.

26.

Lohman

T. G.

Roche

A. F.

Martorell

(1988). Anthropometric standardization reference manual. Human Kinetics Books.

27.

McDonald

Bauer

Capra

Coll

(2014). The muscle mass, omega-3, diet, exercise and lifestyle (MODEL) study – a randomised controlled trial for women who have completed breast cancer treatment. BMC Cancer, 14(1), 264. https://doi.org/10.1186/1471-2407-14-264

28.

McMillan

D. C.

Elahi

M. M.

Sattar

Angerson

W. J.

Johnstone

McArdle

C. S.

(2001). Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutrition and Cancer, 41(1–2), 64–69. https://doi.org/10.1080/01635581.2001.9680613

29.

Mills

R. C.

(2017). Breast cancer survivors, common markers of inflammation, and exercise: A narrative review. Breast Cancer: Basic and Clinical Research, 11, 1178223417743976. https://doi.org/10.1177/1178223417743976.

30.

Mraovic

Radakovic

Ristic-Medic

Dincic

Tepsic-Ostojic

Cairovic

Miljanovic

Radjen

(2018). The relationship between adiposity parameters and C-reactive protein values in overweight and obese women. Vojnosanitetski Pregled, 75(2), 185–190. https://doi.org/10.2298/VSP160419208M

31.

Ornish

Lin

Chan

J. M.

Epel

Kemp

Weidner

Marlin

Frenda

S. J.

Magbanua

M. J. M.

Daubenmier

Estay

Hills

N. K.

Chainani-Wu

Carroll

P. R.

Blackburn

E. H.

(2013). Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. The Lancet Oncology, 14(11), 1112–1120. https://doi.org/10.1016/S1470-2045(13)70366-8

32.

Pannacciulli

Cantatore

F. P.

Minenna

Bellacicco

Giorgino

De Pergola

(2001). C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity, 25(10), 1416–1420. Article 10. https://doi.org/10.1038/sj.ijo.0801719

33.

Pierce

Neuhouser

Wener

Bernstein

Baumgartner

Ballard-Barbash

Gilliland

Baumgartner

Sorensen

McTiernan

Ulrich

(2009b). Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Research and Treatment, 114(1), 155–167. Article 1. https://doi.org/10.1007/s10549-008-9985-5

34.

Pierce

B. L.

Ballard-Barbash

Bernstein

Baumgartner

R. N.

Neuhouser

M. L.

Wener

M. H.

Baumgartner

K. B.

Gilliland

F. D.

Sorensen

B. E.

McTiernan

Ulrich

C. M.

(2009a). Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 27(21), 3437–3444. Article 21. https://doi.org/10.1200/JCO.2008.18.9068

35.

Rangel Peniche

D. B.

Raya Giorguli

Alemán-Mateo

(2015). Accuracy of a predictive bioelectrical impedance analysis equation for estimating appendicular skeletal muscle mass in a non-Caucasian sample of older people. Archives of Gerontology and Geriatrics, 61(1), 39-43. Article 1. https://doi.org/10.1016/j.archger.2015.03.007

36.

Rea

I. M.

Gibson

D. S.

McGilligan

McNerlan

S. E.

Alexander

H. D.

Ross

O. A.

(2018). Age and age-related diseases: Role of inflammation triggers and cytokines. Frontiers in Immunology, 9, 586. https://doi.org/10.3389/fimmu.2018.00586.

37.

Rier

H. N.

Jager

Sleijfer

van Rosmalen

Kock

M. C. J. M.

Levin

M. D.

(2017). Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy. Breast, 31, 9–15. https://doi.org/10.1016/j.breast.2016.10.014.

38.

Rock

C. L.

Doyle

Demark-Wahnefried

Meyerhardt

Courneya

K. S.

Schwartz

A. L.

Bandera

E. V.

Hamilton

K. K.

Grant

McCullough

Byers

Gansler

(2012). Nutrition and physical activity guidelines for cancer survivors. CA: A Cancer Journal for Clinicians, 62(4), 243–274. https://doi.org/10.3322/caac.21142

39.

Rodríguez San Felipe

M. J.

Aguilar Martínez

Manuel-y-Keenoy

(2013). Influencia del peso corporal en el pronóstico de las supervivientes de cáncer de mama: Abordaje nutricional tras el diagnóstico. Nutricion Hospitalaria, 28(6), 1829–1841. Article 6. https://doi.org/10.3305/nh.2013.28.6.6981

40.

Rolland

Lauwers-Cances

Cristini

Abellan van Kan

Janssen

Morley

J. E.

Vellas

(2009). Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: The EPIDOS (EPIDemiologie de l’OSteoporose) study. The American Journal of Clinical Nutrition, 89(6), 1895–1900. Article 6. https://doi.org/10.3945/ajcn.2008.26950

41.

Roxburgh

C. S.

McMillan

D. C.

(2010). Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncology, 6(1), 149–163. https://doi.org/10.2217/fon.09.136

42.

Schaap

L. A.

Pluijm

S. M. F.

Deeg

D. J. H.

Visser

(2006). Inflammatory markers and loss of muscle mass (sarcopenia) and strength. The American Journal of Medicine, 119(6), 526.e9–5526.e17. Article 6. https://doi.org/10.1016/j.amjmed.2005.10.049

43.

Sheng

J. Y.

Sharma

Jerome

Santa-Maria

C. A.

(2018). Obese breast cancer patients and survivors: Management considerations. Oncology, 32(8), 410–417. Article 8.

44.

Tiainen

Hurme

Hervonen

Luukkaala

Jylhä

(2010). Inflammatory markers and physical performance among nonagenarians. The journals of gerontology. Series A, Biological sciences and medical sciences, 65(6), 658–663. Article 6. https://doi.org/10.1093/gerona/glq056

45.

Unger-Saldaña

Bandala-Jacques

Huerta-Gutierrez

Zamora-Muñoz

Hernández-Ávila

J. E.

Cabrera-Galeana

Mohar

Lajous

(2023). Breast cancer survival in Mexico between 2007 and 2016 in women without social security: A retrospective cohort study. Lancet Regional Health-Americas, 23, 100541. https://doi.org/10.1016/j.lana.2023.100541.

46.

Velázquez Alva

M. del. C.

Irigoyen Camacho

M. E.

(2011). Sarcopenia: Una entidad de relevancia clínica actual. Revista de Ciencias Clínicas (México), 12, 22–33.

47.

Villaseñor

Ballard-Barbash

Baumgartner

Bernstein

McTiernan

Neuhouser

M. L.

(2012). Prevalence and prognostic effect of sarcopenia in breast cancer survivors: The HEAL Study. Journal of cancer survivorship: Research and Practice, 6(4), 398–406. Article 4. https://doi.org/10.1007/s11764-012-0234-x

48.

Villasenor

Flatt

S. W.

Marinac

Natarajan

Pierce

J. P.

Patterson

R. E.

(2014). Postdiagnosis C-reactive protein and breast cancer survivorship: Findings from the WHEL study. Cancer Epidemiology, Biomarkers and Prevention: A Publication of the American Association for Cancer Research, 23(1), 189. Article 1. https://doi.org/10.1158/1055-9965.EPI-13-0852

49.

Wang

J.-S.

Cai

Wang

C.-Y.

Zhang

M.-X.

(2014). Body weight changes in breast cancer patients following adjuvant chemotherapy and contributing factors. Molecular and Clinical Oncology, 2(1), 105–110. Article 1. https://doi.org/10.3892/mco.2013.209

50.

World Cancer Research Fund International/American Institute for Cancer Research (2014). Breast cancer survivors report 2014. World Cancer Research Fund International. https://www.wcrf.org/wp-content/uploads/2021/03/Breast-Cancer-Survivors-2014-Report.pdf

51.

Zuñiga

(2015). Conceptos básicos sobre obesidad sarcopénica en el adulto mayor. Revista Clínica Escuela de Medicina UCR-HSJD, 5(3). Article 3. https://doi.org/10.15517/rc_ucr-hsjd.v5i3.19919